Data from the U.S. Department of Health and Human Services Medicaid Provider Spending database show that Medicaid paid a minimum of $1,531 in Clermont during 2024 for services billed with COVID-19-specific HCPCS codes.
Medicaid, a major U.S. health insurance initiative, is managed at the state level and financed through a partnership between state and federal governments. The program serves low-income individuals and families, children, seniors, and those with disabilities.
Since Medicaid dollars are taxpayer-funded, fluctuations in local billing reflect how communities allocate public health resources.
COVID-19 services for this review were identified by HCPCS codes marked as “COVID-19” or “coronavirus” in claims data or code references. Thus, the reported totals account only for services clearly designated as COVID-related on medical billing records; pandemic-influenced care without this label is not reflected.
In comparison, Miami reported the highest amount statewide for Medicaid-paid COVID-19 services in 2024, with virus-related claims reaching $270,279.
Two providers in Clermont submitted Medicaid claims associated with COVID-19 services in 2024. Of these, Immunoassay was among the top codes, totaling $1,215.
The average Medicaid reimbursement per provider for COVID-19 services in Clermont was $766, which is less than the Florida average of $7,271.
COVID-19–related categories fueled much of Clermont’s growth in Medicaid spending during the earlier pandemic years.
From 2020 through 2024, Medicaid payments from categories outside COVID-specific codes rose by $358,537, indicating a 2.8% gain.
The two years before the pandemic saw an average yearly Medicaid payment of $7,585,352 in Clermont.
According to the Centers for Medicare & Medicaid Services, federal and state Medicaid expenditures hit roughly $871.7 billion in fiscal 2023, making up nearly 18% of overall national health spending. That’s a significant increase from about $613.5 billion in 2019, prior to the COVID-19 emergency.
This 40% jump in a few years is primarily the result of coverage expansion and increased health care usage during and following the pandemic.
Recent federal budget measures during the Trump administration proposed a significant restructuring of Medicaid. The “One Big Beautiful Bill Act,” enacted in 2025, is expected to cut more than $1 trillion from federal Medicaid over 10 years and introduces requirements, such as employment mandates and higher cost-sharing, which may affect consumer coverage and program funding. These adjustments are likely to push additional financial responsibility to states and could constrain federal Medicaid growth while the program continues to provide for tens of millions nationwide.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $1,531 | -82.9% | $13,064,784 |
| 2023 | $8,969 | -94.7% | $18,070,685 |
| 2022 | $169,038 | -70% | $17,317,656 |
| 2021 | $562,764 | 64.1% | $13,588,549 |
| 2020 | $343,018 | N/A | $13,047,733 |
| 2019 | $0 | N/A | $11,675,791 |
| 2018 | $0 | N/A | $3,494,913 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $1,215 | 49 |
| 87635 | COVID Specific | $316 | 84 |
Note: Totals only represent HCPCS codes clearly designated for COVID-19 services and do not include all pandemic-related care costs.
This report draws on data from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data are available here.


